Marie Bretagne

1.1k total citations
31 papers, 443 citations indexed

About

Marie Bretagne is a scholar working on Oncology, Surgery and Molecular Biology. According to data from OpenAlex, Marie Bretagne has authored 31 papers receiving a total of 443 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Surgery and 6 papers in Molecular Biology. Recurrent topics in Marie Bretagne's work include Cancer Immunotherapy and Biomarkers (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Renal cell carcinoma treatment (2 papers). Marie Bretagne is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Renal cell carcinoma treatment (2 papers). Marie Bretagne collaborates with scholars based in France, United States and Italy. Marie Bretagne's co-authors include Joe‐Elie Salem, Javid J. Moslehi, Christian Funck‐Brentano, Bénédicte Lebrun‐Vignes, Dan M. Roden, Douglas B. Johnson, Ali Manouchehri, John D. Groarke, Tao Yang and Jennifer R. Brown and has published in prestigious journals such as Journal of the American College of Cardiology, Annals of Oncology and Oncotarget.

In The Last Decade

Marie Bretagne

31 papers receiving 432 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Marie Bretagne France 10 145 117 95 91 91 31 443
Martina Crysandt Germany 12 175 1.2× 109 0.9× 143 1.5× 122 1.3× 97 1.1× 50 519
C. Rusconi Italy 9 142 1.0× 132 1.1× 108 1.1× 57 0.6× 175 1.9× 18 516
Claudia Parolini Italy 14 136 0.9× 66 0.6× 149 1.6× 153 1.7× 34 0.4× 18 465
Shande Tang United States 10 152 1.0× 53 0.5× 97 1.0× 137 1.5× 36 0.4× 15 454
N. Eche France 11 113 0.8× 33 0.3× 61 0.6× 71 0.8× 30 0.3× 25 361
John Frye United States 10 286 2.0× 46 0.4× 172 1.8× 222 2.4× 37 0.4× 24 754
Jan Lemmens Belgium 6 94 0.6× 45 0.4× 47 0.5× 52 0.6× 58 0.6× 12 287
A. Pedersen Denmark 9 202 1.4× 39 0.3× 70 0.7× 93 1.0× 45 0.5× 22 641
David Darmon Israel 9 42 0.3× 94 0.8× 62 0.7× 107 1.2× 29 0.3× 16 410
Sameer S. Talwalkar United States 14 100 0.7× 115 1.0× 51 0.5× 102 1.1× 28 0.3× 26 637

Countries citing papers authored by Marie Bretagne

Since Specialization
Citations

This map shows the geographic impact of Marie Bretagne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marie Bretagne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marie Bretagne more than expected).

Fields of papers citing papers by Marie Bretagne

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marie Bretagne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marie Bretagne. The network helps show where Marie Bretagne may publish in the future.

Co-authorship network of co-authors of Marie Bretagne

This figure shows the co-authorship network connecting the top 25 collaborators of Marie Bretagne. A scholar is included among the top collaborators of Marie Bretagne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marie Bretagne. Marie Bretagne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boussouar, Samia, Etienne Charpentier, Baptiste Abbar, et al.. (2025). Case Report: Immune checkpoint-inhibitor related myotoxicity monitoring using a comprehensive cardiothoracic MRI approach: insights from a clinical case. Frontiers in Cardiovascular Medicine. 12. 1527048–1527048. 1 indexed citations
2.
Bailly, Guillaume, et al.. (2025). Rechallenge After Severe Immune Checkpoint Inhibitor Myocarditis. JACC CardioOncology. 7(3). 300–304. 6 indexed citations
3.
Salem, Joe‐Elie, Stéphane Éderhy, Lisa Belin, et al.. (2024). Abatacept dose-finding phase II triaL for immune checkpoint inhibitors myocarditis (ACHLYS) trial design. Archives of cardiovascular diseases. 118(2). 106–115. 13 indexed citations
4.
Charpentier, Etienne, Samia Boussouar, Marie Bretagne, et al.. (2024). Comprehensive Characterization of Cardiac, Skeletal and Diaphragmatic Myotoxicity Using CMR in Patients with Immune Checkpoint Inhibitor Therapy and Relation to Outcomes. Journal of Cardiovascular Magnetic Resonance. 26. 100680–100680. 1 indexed citations
5.
Jouinot, Anne, Jérôme Alexandre, Marie Bretagne, et al.. (2022). Association of Energy Expenditure and Efficacy in Metastatic Renal Cell Carcinoma Patients Treated with Nivolumab. Cancers. 14(13). 3214–3214. 2 indexed citations
6.
Goulvestre, Claire, Jennifer Arrondeau, Marie Bretagne, et al.. (2022). Preexisting Autoantibodies and Immune Related Adverse Events in Metastatic Urothelial Carcinoma Patients Treated by Pembrolizumab. Clinical Genitourinary Cancer. 20(5). e362–e368. 8 indexed citations
7.
8.
Tlemsani, Camille, Jennifer Arrondeau, Marie Bretagne, et al.. (2021). Impact of the COVID-19 pandemic on the management of cancer patients: the experience of the cancer outpatients department of a university hospital in Paris. Clinical Medicine. 21(5). e552–e555. 2 indexed citations
9.
Salem, Joe‐Elie, Marie Bretagne, Bénédicte Lebrun‐Vignes, et al.. (2019). Clinical characterization of men with long QT syndrome and torsades de pointes associated with hypogonadism: A review and pharmacovigilance study. Archives of cardiovascular diseases. 112(11). 699–712. 16 indexed citations
10.
Bretagne, Marie, Bénédicte Lebrun‐Vignes, Alexandre Pariente, et al.. (2019). Heart failure and atrial tachyarrhythmia on abiraterone: A pharmacovigilance study. Archives of cardiovascular diseases. 113(1). 9–21. 31 indexed citations
11.
Bretagne, Marie, et al.. (2017). Quels biomarqueurs d’avenir ? Le point de vue des internes en oncologie à l’issue du congrès de l’ESMO 2016. Bulletin du Cancer. 104(9). 744–751. 1 indexed citations
12.
Bretagne, Marie, Anne Jouinot, Jean-Philippe Durand, et al.. (2017). Estimation of glomerular filtration rate in cancer patients with abnormal body composition and relation with carboplatin toxicity. Cancer Chemotherapy and Pharmacology. 80(1). 45–53. 19 indexed citations
13.
14.
Bretagne, Marie, Pascaline Boudou‐Rouquette, Olivier Huillard, et al.. (2016). Inhibiteurs de tyrosine kinase ciblant l’angiogenèse et sujets âgés : tolérance, évaluation pré-thérapeutique et gestion des effets indésirables. Bulletin du Cancer. 103(3). 259–272. 4 indexed citations
15.
Bretagne, Marie, Anne Jouinot, Jean-Philippe Durand, et al.. (2016). Estimation of glomerular filtration rate in patients with abnormal body composition and relation with carboplatin toxicity. Annals of Oncology. 27. vi509–vi509. 1 indexed citations
16.
Hoeffel, J C, et al.. (1988). [Idiopathic laryngotracheobronchial calcifications in children. Apropos of 2 cases].. PubMed. 69(3). 217–21. 4 indexed citations
17.
Hoeffel, J. M., et al.. (1986). Pulmonary sequestrations of the upper lobe in children: Three presentations. RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 144(5). 542–545. 2 indexed citations
18.
Habibi, B., Jean‐Pierre Cartron, Marie Bretagne, P. Rouger, & C Salmon. (1981). Anti‐Nomifensine Antibody Causing Immune Hemolytic Anemia and Renal Failure. Vox Sanguinis. 40(2). 79–84. 16 indexed citations
19.
Bretagne, Marie, et al.. (1977). A propos de périostite... ou plutôt d'appositions périostées en pédiatrie. 58(2). 1 indexed citations
20.
Bretagne, Marie. (1965). [Clinical trials of a new anticholinesterase agent, galanthamine, in anesthesiology].. PubMed. 22(10). 285–48. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Martina Crysandt Breakdown of academic impact, for papers by C. Rusconi Breakdown of academic impact, for papers by Claudia Parolini Breakdown of academic impact, for papers by Shande Tang Breakdown of academic impact, for papers by N. Eche Breakdown of academic impact, for papers by John Frye Breakdown of academic impact, for papers by Jan Lemmens Breakdown of academic impact, for papers by A. Pedersen Breakdown of academic impact, for papers by David Darmon Breakdown of academic impact, for papers by Sameer S. Talwalkar
Rankless by CCL
2026